Olivier Namy

Dr. Olivier Namy

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2006 in Nature
Verified
Journal Article
Closed access
PDF file
ONOlivier Namy
Olivier Namy
SMStephen J. Moran
Stephen J. Moran
DSDavid Ian Stuart
David Ian Stuart
RGRobert J. C. Gilbert
Robert J. C. Gilbert
IBIan Brierley
Ian Brierley

20 November 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JEJenny Erales
Jenny Erales
VMVirginie Marchand
Virginie Marchand
BPBaptiste Panthu
Baptiste Panthu
SGSandra Gillot
Sandra Gillot
Stephane BELINStephane BELIN
Stephane BELIN
Jean-Jacques DiazJean-Jacques Diaz
Jean-Jacques Diaz
Significance: Translational control is a cornerstone of gene-expression regulation in physiological and pathological contexts. The contribution of nonribosomal factors, including messenger RNAs (mRNAs) and mRNA-bound factors, to translational control have been extensively studied. Recently, the hypothesis of a ribosome-mediated regulation emerged, which proposes that cells produce ribosomes of different composition and displaying different translational properties. This work reveals that ribosomal RNA 2′-O-methylation can be modulated in human ribosomes, including at key functional sites for translation, and that changes in the 2′-O-methylation pattern control the intrinsic capabilities of ribosomes to translate mRNAs. This work directly demonstrates the existence of composition-modified ribosomes and their associated change in translational activity as conceptualized by the specialized ribosome concept.

1 September 2001 in EMBO Reports
Verified
Journal Article
Open access
PDF file
ONOlivier Namy
Olivier Namy
IHIsabelle Hatin
Isabelle Hatin
JRJean‐Pierre Rousset
Jean‐Pierre Rousset
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 January 2004 in Molecular Cell
Verified
Journal Article
Closed access
ONOlivier Namy
Olivier Namy
JRJean-Pierre Rousset
Jean-Pierre Rousset
SNSawsan Napthine
Sawsan Napthine
IBIan Brierley
Ian Brierley

1 November 2012 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
LBLaure Bidou
Laure Bidou
VAValérie Allamand
Valérie Allamand
JRJean-Pierre Rousset
Jean-Pierre Rousset
ONOlivier Namy
Olivier Namy

1 May 2003 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ONOlivier Namy
Olivier Namy
GDGuillemette Duchateau‐Nguyen
Guillemette Duchateau‐Nguyen
IHIsabelle Hatin
Isabelle Hatin
SDSylvie Hermann‐Le Denmat
Sylvie Hermann‐Le Denmat
MTMichel Termier
Michel Termier
JRJean‐Pierre Rousset
Jean‐Pierre Rousset
We specifically sought genes within the yeast genome controlled by a non‐conventional translation mechanism involving the stop codon. For this reason, we designed a computer program using the yeast database genomic regions, and seeking two adjacent open reading frames separated only by a unique stop codon (called SORFs). Among the 58 SORFs identified, eight displayed a stop codon bypass level ranging from 3 to 25%. For each of the eight sequences, we demonstrated the presence of a poly(A) mRNA. Using isogenic [PSI+] and [psi–] yeast strains, we showed that for two of the sequences the mechanism used is a bona fide readthrough. However, the six remaining sequences were not sensitive to the PSI state, indicating either a translation termination process independent of eRF3 or a new stop codon bypass mechanism. Our results demonstrate that the presence of a stop codon in a large ORF may not always correspond to a sequencing error, or a pseudogene, but can be a recoding signal in a functional gene. This emphasizes that genome annotation should take into account the fact that recoding signals could be more frequently used than previously expected.